Radiotherapy Cuts Myeloma Risk in Rare Head and Neck Cancer

Radiotherapy had a distinct advantage over surgery in reducing myeloma progression while maintaining comparable survival outcomes in patients with extramedullary plasmacytoma.
Medscape Medical News